Why Microsoft's Yammer Buyout Matters in Pharma

Microsoft has plans to step up its focus on social networking with its expected buyout of the business social network Yammer for more than $1 billion. And The Wall Street Journal caught up with the tech chief at AstraZeneca, among others, in a piece that gauges the import of the major buyout across several different sectors.
June 28, 2012
Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates